Sign In
Buy IART
$16.10
+0.430 (+2.74%)
At Close: Jun 03, 2026
Integra LifeSciences Holdings Corporation (IART) CEO Jan De Witte on Q2 2022 Results - Earnings Call Transcript
03:32pm, Wednesday, 27'th Jul 2022
Integra LifeSciences Holdings Corporation (NASDAQ:IART ) Q2 2022 Earnings Conference Call July 27, 2022 8:30 AM ET Company Participants Chris Ward - Senior Director, Investor Relations Jan De Witte -
Integra LifeSciences (IART) Tops Q2 Earnings and Revenue Estimates
10:07am, Wednesday, 27'th Jul 2022
Integra (IART) delivered earnings and revenue surprises of 2.50% and 0.83%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Integra LifeSciences to Host Second Quarter 2022 Financial Results Conference Call on July 27, 2022
04:00pm, Friday, 01'st Jul 2022
PRINCETON, N.J., July 01, 2022 (GLOBE NEWSWIRE) -- ) Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2022 financial
Here's Why Investors Should Retain Integra (IART) Stock for Now
12:48pm, Wednesday, 01'st Jun 2022
Investors are optimistic about Integra's (IART) better-than-expected results and strong performance across several geographies.
Why Integra LifeSciences (IART) is a Top Value Stock for the Long-Term
11:18am, Tuesday, 31'st May 2022
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Integra (IART) Gains From Innovation Amid Cost Constraints
09:48am, Tuesday, 31'st May 2022
Integra's (IART) international sales in CSS grow led by the strong performance of CereLink in Europe and growth in Asia.
Integra (IART) Q1 Earnings Top Estimates, Margins Expand
09:47am, Monday, 02'nd May 2022
Integra's (IART) updated 2022 financial guidance calls for strong year-over-year organic growth.
IART vs. EW: Which Stock Is the Better Value Option?
12:47pm, Thursday, 28'th Apr 2022
IART vs. EW: Which Stock Is the Better Value Option?
Integra LifeSciences Holdings Corporation (IART) CEO Jan De Witte on Q1 2022 Results - Earnings Call Transcript
12:53pm, Wednesday, 27'th Apr 2022
Integra LifeSciences Holdings Corporation (NASDAQ:IART ) Q1 2022 Earnings Conference Call April 27, 2022 8:30 AM ET Company Participants Jan De Witte – President & Chief Executive Officer Glenn Cole
Integra LifeSciences (IART) Tops Q1 Earnings and Revenue Estimates
08:17am, Wednesday, 27'th Apr 2022
Integra (IART) delivered earnings and revenue surprises of 8.82% and 3.87%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's Why You Should Retain Integra (IART) Stock For Now
12:48pm, Friday, 22'nd Apr 2022
Investors are optimistic about Integra (IART), given the strength in its CSS arm and notable product launches.
Earnings Preview: Integra LifeSciences (IART) Q1 Earnings Expected to Decline
04:34pm, Wednesday, 20'th Apr 2022
Integra (IART) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Integra LifeSciences to Host First Quarter 2022 Financial Results Conference Call on April 27, 2022
08:08am, Friday, 01'st Apr 2022
PRINCETON, N.J., April 01, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release first quarter 2022 financial r
Integra (IART) Down 3.9% Since Last Earnings Report: Can It Rebound?
01:32pm, Friday, 25'th Mar 2022
Integra (IART) reported earnings 30 days ago. What's next for the stock?
Integra (IART) Debuts NeuraGen 3D for Peripheral Nerve Repair
10:32am, Wednesday, 23'rd Mar 2022
Integra's (IART) NeuraGen 3D will provide surgeons with access to the latest technology in peripheral nerve repair.
